Brandywine Global Investment Management, LLC Collegium Pharmaceutical, Inc Transaction History
Brandywine Global Investment Management, LLC
- $13.4 Billion
- Q4 2024
A detailed history of Brandywine Global Investment Management, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Brandywine Global Investment Management, LLC holds 100,971 shares of COLL stock, worth $3.02 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
100,971
Previous 250,373
59.67%
Holding current value
$3.02 Million
Previous $9.67 Million
70.11%
% of portfolio
0.02%
Previous 0.07%
Shares
25 transactions
Others Institutions Holding COLL
# of Institutions
246Shares Held
37.2MCall Options Held
59.3KPut Options Held
9.5K-
Black Rock Inc. New York, NY5.79MShares$173 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$78.9 Million1.45% of portfolio
-
Rubric Capital Management LP New York, NY2.35MShares$70.3 Million1.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$68.3 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$64.1 Million0.15% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.02B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...